Michael A. Zasloff, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 7,692 shares at $17.41 ($134K) on 2015-07-17, disclosed to the SEC on 2015-07-21.
Scheduled sale ($134k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMPH | SELL | 2023-05-16 | $316K | — | Filing → |
| AMPH | SELL | 2022-05-17 | $733K | — | Filing → |
| AMPH | SELL | 2022-03-17 | $337K | — | Filing → |